array(40) {
  [0]=>
  string(4) "1608"
  ["article_id"]=>
  string(4) "1608"
  [1]=>
  string(52) "Opioid Use in Pregnancy Tied to Severe Birth Defects"
  ["article_title"]=>
  string(52) "Opioid Use in Pregnancy Tied to Severe Birth Defects"
  [2]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- More American infants are being born with their intestines outside of their bodies, and the disturbing trend might be linke"
  ["short_description"]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- More American infants are being born with their intestines outside of their bodies, and the disturbing trend might be linke"
  [3]=>
  string(252) "THURSDAY, Jan. 17, 2019 -- More American infants are being born with their intestines outside of their bodies, and the disturbing trend might be linked to the opioid crisis, health officials reported Thursday.&#nlThe condition, called gastroschisis,..."
  ["description"]=>
  string(252) "THURSDAY, Jan. 17, 2019 -- More American infants are being born with their intestines outside of their bodies, and the disturbing trend might be linked to the opioid crisis, health officials reported Thursday.&#nlThe condition, called gastroschisis,..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(176) "https://www.drugs.com/news/opioid-pregnancy-tied-severe-birth-defects-79816.html?utm_source=ddc&utm_medium=rss&utm_campaign=Opioid+Use+in+Pregnancy+Tied+to+Severe+Birth+Defects"
  ["blog_url"]=>
  string(176) "https://www.drugs.com/news/opioid-pregnancy-tied-severe-birth-defects-79816.html?utm_source=ddc&utm_medium=rss&utm_campaign=Opioid+Use+in+Pregnancy+Tied+to+Severe+Birth+Defects"
  [15]=>
  string(19) "2019-01-17 22:01:33"
  ["add_date"]=>
  string(19) "2019-01-17 22:01:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1646"
  ["article_id"]=>
  string(4) "1646"
  [1]=>
  string(104) "Lack of leadership and clinical skills are a 'barrier' to pharmacy investment, warns NHS England"
  ["article_title"]=>
  string(104) "Lack of leadership and clinical skills are a 'barrier' to pharmacy investment, warns NHS England"
  [2]=>
  string(167) "A lack of “skill mix” among pharmacists is a potential barrier to investment in the sector as part of the ‘NHS Long-Term Plan’, the deputy chi"
  ["short_description"]=>
  string(167) "A lack of “skill mix” among pharmacists is a potential barrier to investment in the sector as part of the ‘NHS Long-Term Plan’, the deputy chi"
  [3]=>
  string(216) "A lack of “skill mix” among pharmacists is a potential barrier to investment in the sector as part of the ‘NHS Long-Term Plan’, the deputy chief pharmaceutical officer for England has warned."
  ["description"]=>
  string(216) "A lack of “skill mix” among pharmacists is a potential barrier to investment in the sector as part of the ‘NHS Long-Term Plan’, the deputy chief pharmaceutical officer for England has warned."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(172) "https://www.pharmaceutical-journal.com/news-and-analysis/news/lack-of-leadership-and-clinical-skills-are-a-barrier-to-pharmacy-investment-warns-nhs-england/20206017.article"
  ["blog_url"]=>
  string(172) "https://www.pharmaceutical-journal.com/news-and-analysis/news/lack-of-leadership-and-clinical-skills-are-a-barrier-to-pharmacy-investment-warns-nhs-england/20206017.article"
  [15]=>
  string(19) "2019-01-17 21:43:00"
  ["add_date"]=>
  string(19) "2019-01-17 21:43:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:18"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:18"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1647"
  ["article_id"]=>
  string(4) "1647"
  [1]=>
  string(80) "DHSC to consult with pharmaceutical industry over generics price limiting powers"
  ["article_title"]=>
  string(80) "DHSC to consult with pharmaceutical industry over generics price limiting powers"
  [2]=>
  string(150) "The Department of Health and Social Care will consult with the pharmaceutical industry over its plans to use new powers limiting the price of generics"
  ["short_description"]=>
  string(150) "The Department of Health and Social Care will consult with the pharmaceutical industry over its plans to use new powers limiting the price of generics"
  [3]=>
  string(205) "The Department of Health and Social Care will consult with the pharmaceutical industry over its plans to use new powers limiting the price of generics, the department’s permanent secretary has said."
  ["description"]=>
  string(205) "The Department of Health and Social Care will consult with the pharmaceutical industry over its plans to use new powers limiting the price of generics, the department’s permanent secretary has said."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(168) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/dhsc-to-consult-with-pharmaceutical-industry-over-generics-price-limiting-powers/20206006.article"
  ["blog_url"]=>
  string(168) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/dhsc-to-consult-with-pharmaceutical-industry-over-generics-price-limiting-powers/20206006.article"
  [15]=>
  string(19) "2019-01-17 21:26:00"
  ["add_date"]=>
  string(19) "2019-01-17 21:26:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:18"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:18"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1588"
  ["article_id"]=>
  string(4) "1588"
  [1]=>
  string(41) "PharmaTimes CROY 2019 - deadline extended"
  ["article_title"]=>
  string(41) "PharmaTimes CROY 2019 - deadline extended"
  [2]=>
  string(146) "It’s not too late! The deadline for the PharmaTimes Clinical Researcher of the Year (CROY) 2019 awards has been extended to the February 25."
  ["short_description"]=>
  string(146) "It’s not too late! The deadline for the PharmaTimes Clinical Researcher of the Year (CROY) 2019 awards has been extended to the February 25."
  [3]=>
  string(146) "It’s not too late! The deadline for the PharmaTimes Clinical Researcher of the Year (CROY) 2019 awards has been extended to the February 25."
  ["description"]=>
  string(146) "It’s not too late! The deadline for the PharmaTimes Clinical Researcher of the Year (CROY) 2019 awards has been extended to the February 25."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(81) "http://www.pharmatimes.com/news/pharmatimes_croy_2019_-_deadline_extended_1275453"
  ["blog_url"]=>
  string(81) "http://www.pharmatimes.com/news/pharmatimes_croy_2019_-_deadline_extended_1275453"
  [15]=>
  string(19) "2019-01-17 20:27:57"
  ["add_date"]=>
  string(19) "2019-01-17 20:27:57"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1589"
  ["article_id"]=>
  string(4) "1589"
  [1]=>
  string(55) "NICE approval for Verzenios in metastatic breast cancer"
  ["article_title"]=>
  string(55) "NICE approval for Verzenios in metastatic breast cancer"
  [2]=>
  string(150) "The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatm"
  ["short_description"]=>
  string(150) "The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatm"
  [3]=>
  string(209) "The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatment option for locally advanced or metastatic breast cancer"
  ["description"]=>
  string(209) "The National Institute for Health and Care Excellence has recommended Eli Lilly’s Verzenios in combination with an aromatase inhibitor as treatment option for locally advanced or metastatic breast cancer"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(95) "http://www.pharmatimes.com/news/nice_approval_for_verzenios_in_metastatic_breast_cancer_1275534"
  ["blog_url"]=>
  string(95) "http://www.pharmatimes.com/news/nice_approval_for_verzenios_in_metastatic_breast_cancer_1275534"
  [15]=>
  string(19) "2019-01-17 20:22:17"
  ["add_date"]=>
  string(19) "2019-01-17 20:22:17"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1590"
  ["article_id"]=>
  string(4) "1590"
  [1]=>
  string(49) "EU licence granted for Erleada in prostate cancer"
  ["article_title"]=>
  string(49) "EU licence granted for Erleada in prostate cancer"
  [2]=>
  string(103) "Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission."
  ["short_description"]=>
  string(103) "Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission."
  [3]=>
  string(103) "Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission."
  ["description"]=>
  string(103) "Janssen’s new treatment for prostate cancer Erleada has been licensed by the European Commission."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(89) "http://www.pharmatimes.com/news/eu_licence_granted_for_erleada_in_prostate_cancer_1275526"
  ["blog_url"]=>
  string(89) "http://www.pharmatimes.com/news/eu_licence_granted_for_erleada_in_prostate_cancer_1275526"
  [15]=>
  string(19) "2019-01-17 20:16:15"
  ["add_date"]=>
  string(19) "2019-01-17 20:16:15"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1591"
  ["article_id"]=>
  string(4) "1591"
  [1]=>
  string(35) "Scholl and COP announce partnership"
  ["article_title"]=>
  string(35) "Scholl and COP announce partnership"
  [2]=>
  string(126) "Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health."
  ["short_description"]=>
  string(126) "Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health."
  [3]=>
  string(126) "Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health."
  ["description"]=>
  string(126) "Footcare brand Scholl has announced it is joining forces with The College of Podiatry (COP) to raise awareness of foot health."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(75) "http://www.pharmatimes.com/news/scholl_and_cop_announce_partnership_1275457"
  ["blog_url"]=>
  string(75) "http://www.pharmatimes.com/news/scholl_and_cop_announce_partnership_1275457"
  [15]=>
  string(19) "2019-01-17 20:12:42"
  ["add_date"]=>
  string(19) "2019-01-17 20:12:42"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1648"
  ["article_id"]=>
  string(4) "1648"
  [1]=>
  string(88) "'Rouse Ltd (Chemist) of Wigmore Street', a 1953 oil painting by John Vicat Cole "
  ["article_title"]=>
  string(88) "'Rouse Ltd (Chemist) of Wigmore Street', a 1953 oil painting by John Vicat Cole "
  [2]=>
  string(106) "This painting captures in detail the exterior of Rouse’s pharmacy at 12 Wigmore Street, London, W1."
  ["short_description"]=>
  string(106) "This painting captures in detail the exterior of Rouse’s pharmacy at 12 Wigmore Street, London, W1."
  [3]=>
  string(106) "This painting captures in detail the exterior of Rouse’s pharmacy at 12 Wigmore Street, London, W1."
  ["description"]=>
  string(106) "This painting captures in detail the exterior of Rouse’s pharmacy at 12 Wigmore Street, London, W1."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(139) "https://www.pharmaceutical-journal.com/your-rps/rouse-ltd-chemist-of-wigmore-street-a-1953-oil-painting-by-john-vicat-cole/20205994.article"
  ["blog_url"]=>
  string(139) "https://www.pharmaceutical-journal.com/your-rps/rouse-ltd-chemist-of-wigmore-street-a-1953-oil-painting-by-john-vicat-cole/20205994.article"
  [15]=>
  string(19) "2019-01-17 20:11:00"
  ["add_date"]=>
  string(19) "2019-01-17 20:11:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:18"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:18"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1609"
  ["article_id"]=>
  string(4) "1609"
  [1]=>
  string(57) "Experimental Drug Could Be New Option for Type 2 Diabetes"
  ["article_title"]=>
  string(57) "Experimental Drug Could Be New Option for Type 2 Diabetes"
  [2]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously "
  ["short_description"]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously "
  [3]=>
  string(254) "THURSDAY, Jan. 17, 2019 -- An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously low levels.&#nlResearchers found that the compound -- dubbed TTP399 for now -- improved patients'..."
  ["description"]=>
  string(254) "THURSDAY, Jan. 17, 2019 -- An experimental drug may help people with type 2 diabetes curb their blood sugar without causing it to drop to dangerously low levels.&#nlResearchers found that the compound -- dubbed TTP399 for now -- improved patients'..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "5"
  ["rss_id"]=>
  string(1) "5"
  [14]=>
  string(184) "https://www.drugs.com/news/experimental-could-new-option-type-2-diabetes-79802.html?utm_source=ddc&utm_medium=rss&utm_campaign=Experimental+Drug+Could+Be+New+Option+for+Type+2+Diabetes"
  ["blog_url"]=>
  string(184) "https://www.drugs.com/news/experimental-could-new-option-type-2-diabetes-79802.html?utm_source=ddc&utm_medium=rss&utm_campaign=Experimental+Drug+Could+Be+New+Option+for+Type+2+Diabetes"
  [15]=>
  string(19) "2019-01-17 20:01:14"
  ["add_date"]=>
  string(19) "2019-01-17 20:01:14"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1630"
  ["article_id"]=>
  string(4) "1630"
  [1]=>
  string(51) "Asthma Undiagnosed in One in Five Urban Adolescents"
  ["article_title"]=>
  string(51) "Asthma Undiagnosed in One in Five Urban Adolescents"
  [2]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- The prevalence of undiagnosed asthma is 20.2 percent among urban adolescents, according to a study published online Jan. 15"
  ["short_description"]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- The prevalence of undiagnosed asthma is 20.2 percent among urban adolescents, according to a study published online Jan. 15"
  [3]=>
  string(255) "THURSDAY, Jan. 17, 2019 -- The prevalence of undiagnosed asthma is 20.2 percent among urban adolescents, according to a study published online Jan. 15 in the Journal of Urban Health.&#nlJean-Marie Bruzzese, Ph.D., from the Columbia University School of..."
  ["description"]=>
  string(255) "THURSDAY, Jan. 17, 2019 -- The prevalence of undiagnosed asthma is 20.2 percent among urban adolescents, according to a study published online Jan. 15 in the Journal of Urban Health.&#nlJean-Marie Bruzzese, Ph.D., from the Columbia University School of..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(178) "https://www.drugs.com/news/asthma-undiagnosed-one-five-urban-adolescents-79815.html?utm_source=ddc&utm_medium=rss&utm_campaign=Asthma+Undiagnosed+in+One+in+Five+Urban+Adolescents"
  ["blog_url"]=>
  string(178) "https://www.drugs.com/news/asthma-undiagnosed-one-five-urban-adolescents-79815.html?utm_source=ddc&utm_medium=rss&utm_campaign=Asthma+Undiagnosed+in+One+in+Five+Urban+Adolescents"
  [15]=>
  string(19) "2019-01-17 20:00:32"
  ["add_date"]=>
  string(19) "2019-01-17 20:00:32"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1631"
  ["article_id"]=>
  string(4) "1631"
  [1]=>
  string(58) "Temporary Impairment in HRQOL After Teen Sports Concussion"
  ["article_title"]=>
  string(58) "Temporary Impairment in HRQOL After Teen Sports Concussion"
  [2]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- Adolescent sports-related concussion (SRC) is associated with temporary impairments in health-related quality of life (HRQO"
  ["short_description"]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- Adolescent sports-related concussion (SRC) is associated with temporary impairments in health-related quality of life (HRQO"
  [3]=>
  string(255) "THURSDAY, Jan. 17, 2019 -- Adolescent sports-related concussion (SRC) is associated with temporary impairments in health-related quality of life (HRQOL), according to a study published online Jan. 15 in the Journal of Neurosurgery: Pediatrics.&#nlKelly..."
  ["description"]=>
  string(255) "THURSDAY, Jan. 17, 2019 -- Adolescent sports-related concussion (SRC) is associated with temporary impairments in health-related quality of life (HRQOL), according to a study published online Jan. 15 in the Journal of Neurosurgery: Pediatrics.&#nlKelly..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(195) "https://www.drugs.com/news/temporary-impairment-hrqol-after-teen-sports-concussion-79808.html?utm_source=ddc&utm_medium=rss&utm_campaign=Temporary+Impairment+in+HRQOL+After+Teen+Sports+Concussion"
  ["blog_url"]=>
  string(195) "https://www.drugs.com/news/temporary-impairment-hrqol-after-teen-sports-concussion-79808.html?utm_source=ddc&utm_medium=rss&utm_campaign=Temporary+Impairment+in+HRQOL+After+Teen+Sports+Concussion"
  [15]=>
  string(19) "2019-01-17 20:00:29"
  ["add_date"]=>
  string(19) "2019-01-17 20:00:29"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "1632"
  ["article_id"]=>
  string(4) "1632"
  [1]=>
  string(58) "Breast Cancer Patients Do Not Overreact to Genetic Testing"
  ["article_title"]=>
  string(58) "Breast Cancer Patients Do Not Overreact to Genetic Testing"
  [2]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a "
  ["short_description"]=>
  string(150) "THURSDAY, Jan. 17, 2019 -- Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a "
  [3]=>
  string(246) "THURSDAY, Jan. 17, 2019 -- Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a study recently published in JCO Precision Oncology.&#nlSteven J. Katz, M.D., M.P.H., from the..."
  ["description"]=>
  string(246) "THURSDAY, Jan. 17, 2019 -- Among breast cancer patients, more extensive genetic testing is not associated with increased cancer worry, according to a study recently published in JCO Precision Oncology.&#nlSteven J. Katz, M.D., M.P.H., from the..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "6"
  ["rss_id"]=>
  string(1) "6"
  [14]=>
  string(195) "https://www.drugs.com/news/breast-cancer-patients-do-not-overreact-genetic-testing-79806.html?utm_source=ddc&utm_medium=rss&utm_campaign=Breast+Cancer+Patients+Do+Not+Overreact+to+Genetic+Testing"
  ["blog_url"]=>
  string(195) "https://www.drugs.com/news/breast-cancer-patients-do-not-overreact-genetic-testing-79806.html?utm_source=ddc&utm_medium=rss&utm_campaign=Breast+Cancer+Patients+Do+Not+Overreact+to+Genetic+Testing"
  [15]=>
  string(19) "2019-01-17 20:00:19"
  ["add_date"]=>
  string(19) "2019-01-17 20:00:19"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-01-21 08:05:16"
  ["create_at"]=>
  string(19) "2019-01-21 08:05:16"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}